Cargando…

High serum CCL20 is associated with tumor progression in penile cancer

Serum cancer biomarker has been proven to be very valuable in cancer diagnosis, disease monitoring and prognosis assessment, despite there is still a lack of serum biomarker for penile cancer (PC). Our initial analysis on public GEO dataset identified CCL20 as a top C-C motif ligand (CCL) gene enric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mo, Miao, Tong, Shiyu, Huang, Wei, Cai, Yi, Zu, Xiongbing, Hu, Xiheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591991/ https://www.ncbi.nlm.nih.gov/pubmed/33123272 http://dx.doi.org/10.7150/jca.48939

Ejemplares similares

Serum CXCL13 Level is Associated with Tumor Progression and Unfavorable Prognosis in Penile Cancer
por: Mo, Miao, et al.
Publicado: (2020)

Serum CXCL5 level is associated with tumor progression in penile cancer
por: Mo, Miao, et al.
Publicado: (2021)

RGS20 Promotes Tumor Progression through Modulating PI3K/AKT Signaling Activation in Penile Cancer
por: Shi, Dazun, et al.
Publicado: (2022)

Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma
por: Mo, Miao, et al.
Publicado: (2021)

Competing endogenous RNA network analysis reveals pivotal ceRNAs in bladder urothelial carcinoma
por: Li, Yangle, et al.
Publicado: (2021)

LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer
por: Li, Chao, et al.
Publicado: (2021)

miR-150 Modulates Cisplatin Chemosensitivity and Invasiveness of Muscle-Invasive Bladder Cancer Cells via Targeting PDCD4 In Vitro
por: Lei, Ye, et al.
Publicado: (2014)

Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical Nephroureterectomy
por: Long, Xingbo, et al.
Publicado: (2016)

An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer
por: Xiao, Zicheng, et al.
Publicado: (2022)

Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer
por: Li, Yangle, et al.
Publicado: (2019)

miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells
por: Lei, Ye, et al.
Publicado: (2015)

Comparison of efficacy between brachytherapy and penectomy in patients with penile cancer: a meta-analysis
por: Hu, Xiheng, et al.
Publicado: (2017)

The CCL20-CCR6 Axis in Cancer Progression
por: Kadomoto, Suguru, et al.
Publicado: (2020)

MEST promotes bladder cancer cell proliferation, migration and invasion via STAT3/Twist-1-mediated EMT
por: Zhao, Cheng, et al.
Publicado: (2020)

Predictors of inguinal lymph node metastasis in penile cancer patients: a meta-analysis of retrospective studies
por: Hu, Jiao, et al.
Publicado: (2019)

Aberrant CEACAM19 expression is associated with metastatic phenotype in penile cancer
por: Hu, Xiheng, et al.
Publicado: (2019)

EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer
por: Li, Yimin, et al.
Publicado: (2020)

Serum concentrations of CCL20/MIP-3alpha in women with endometriosis
por: Jabłoński, Grzegorz, et al.
Publicado: (2019)

ERα-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion
por: Wu, Longxiang, et al.
Publicado: (2019)

Prostate‐specific antigen modulates the osteogenic differentiation of MSCs via the cadherin 11‐Akt axis
por: Wu, Longxiang, et al.
Publicado: (2020)

CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition
por: Fan, Tao, et al.
Publicado: (2022)

Comparison of clinical feasibility and oncological outcomes between video endoscopic and open inguinal lymphadenectomy for penile cancer: A systematic review and meta-analysis
por: Hu, Jiao, et al.
Publicado: (2019)

The Correlation of Serums CCL11, CCL17, CCL26, and CCL27 and Disease Severity in Patients with Urticaria
por: Lu, Tao, et al.
Publicado: (2016)

Involvement of CCR6/CCL20/IL-17 Axis in NSCLC Disease Progression
por: Kirshberg, Sophie, et al.
Publicado: (2011)

Interaction between CXCR4 and CCL20 Pathways Regulates Tumor Growth
por: Beider, Katia, et al.
Publicado: (2009)

Glucocorticoids promote CCL20 expression in keratinocytes
por: Wang, L., et al.
Publicado: (2021)

Induced expression of CCL19 promotes the anti-tumor ability of CAR-T cells by increasing their infiltration ability
por: Hu, Jian-fei, et al.
Publicado: (2022)

Long noncoding RNA MAFG-AS1 facilitates bladder cancer tumorigenesis via regulation of miR-143-3p/SERPINE1 axis
por: Sun, Xi, et al.
Publicado: (2020)

A role for CCL2 in both tumor progression and immunosurveillance
por: Li, Ming, et al.
Publicado: (2013)

CCL20 is a potential therapeutic target associated with immune infiltration in breast cancer
por: Zhai, Hongyan, et al.
Publicado: (2023)

Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20‐CCR6 pathway
por: Lian, Jingyao, et al.
Publicado: (2020)

Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
por: Wang, Dan, et al.
Publicado: (2019)

ATXN3 promotes prostate cancer progression by stabilizing YAP
por: Wu, Longxiang, et al.
Publicado: (2023)

Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression
por: Kwantwi, Louis Boafo, et al.
Publicado: (2021)

Relationship between serum and synovial fluid CCL20 concentrations with disease severity in primary knee osteoarthritis
por: Guan, Jian, et al.
Publicado: (2019)

Anterior versus posterior approach laparoscopic radical cystectomy: a retrospective analysis
por: Tong, Shiyu, et al.
Publicado: (2019)

Selective Recruitment of Regulatory T Cell through CCR6-CCL20 in Hepatocellular Carcinoma Fosters Tumor Progression and Predicts Poor Prognosis
por: Chen, Kang-Jie, et al.
Publicado: (2011)

CCL18 in the Progression of Cancer
por: Korbecki, Jan, et al.
Publicado: (2020)

Pneumoperitoneum Modifies Serum and Tissue CCL2-CCL5 Expression in Mice
por: Papparella, Alfonso, et al.
Publicado: (2020)

Correction to: Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
por: Wang, Dan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_623m17e2draf79f1sm4j0vietq